Abstract
Recombinant human erythropoietin (rHuEPO) is effective in managing chronic kidney disease and chemotherapy-induced anemia. However, hyporesponsiveness......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
